InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Sciascia Thomas. Insider active across 1 company, notably Trevi Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. Activity tracked since 29 May 2024. The latest transaction was filed on 25 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
SCIASCIA THOMAS is a declarant linked to Trevi Therapeutics, Inc. as Chief Scientific Officer. The record shows 4 filings in total, and the sampled recent filings run from 2024-05-31 to 2025-03-26, with the modal transaction nature listed as option exercise. The buy and sell volumes in this sample are EUR 0 and EUR 0.